What is Genome Medical?
Headquartered in South San Francisco, Genome Medical operates as a sophisticated telehealth-based medical practice. The company leverages a multi-modal digital infrastructure—including video conferencing, secure messaging, and shared imaging—to deliver high-quality clinical care and health-related education. By integrating genomics into routine clinical practice, the firm bridges the gap between complex molecular diagnostics and patient-facing health administration. Its market position is defined by its ability to provide scalable, remote access to specialized medical expertise, effectively democratizing precision medicine for diverse patient populations and healthcare delivery systems.
How much funding has Genome Medical raised?
Genome Medical has raised a total of $120M across 3 funding rounds:
Series A
$23M
Series B
$37M
Series C
$60M
Series A (2017): $23M with participation from Canaan Partners, HealthInvest Equity Partners, Flywheel Ventures, and Illumina Ventures
Series B (2020): $37M led by LRVHealth, HealthInvest Equity Partners, Avestria Ventures, Revelation Partners, Samsung Electronics America, Kaiser Permanente Ventures, Illumina Ventures, Echo Health Ventures, Dreamers Fund, Flywheel Ventures, Perceptive Advisors, Manatt Venture Fund, Randy Scott, Casdin Capital, Canaan Partners, and GE Ventures
Series C (2021): $60M supported by Perceptive Advisors, Amgen Ventures, Kaiser Permanente Ventures, Casdin Capital, GV, and Canaan Partners
Key Investors in Genome Medical
Kaiser Permanente Ventures
A national leader in strategic venture investing in healthcare, focusing on advancing innovation and integrating new approaches into established delivery systems.
Casdin Capital
An investment firm bringing deep expertise to the financing of next-generation life science innovation, with a specific focus on diagnostics and molecular information.
Illumina Ventures
A prominent leader in genomics and precision health investing, dedicated to building an ecosystem that translates capital into impactful life science and biopharmaceutical solutions.
What's next for Genome Medical?
With the support of its latest financing, Genome Medical is well-positioned to accelerate its mission of integrating genomic insights into mainstream healthcare. The strategic focus will likely shift toward enhancing its digital platform capabilities and deepening partnerships with large-scale healthcare providers. As the industry moves toward more personalized, data-driven care models, the company is poised to leverage its existing infrastructure to capture a larger share of the digital health market. Future growth will likely involve expanding its clinical network and refining its diagnostic support tools to meet the increasing demand for remote, high-acuity medical services.
See full Genome Medical company page
